Work Package 6: Economic Effectiveness

background

Work package 6 has the following objectives:

1. Estimate costs and health benefits associated with the interventions, including estimation of quality of life impact of infections.

2. Perform cost-effectiveness evaluations accounting for heterogeneity based on the clinical trial results.

3. Perform cost-effectiveness evaluations beyond the trial duration incorporating the impact on resistance and its health and cost consequences in the long term.

4. Conduct budget-impact analyses to provide estimates of affordability of tested interventions in different resource settings.

5. Identify potential barriers and facilitators of implementation in two selected low-and-middle-income countries.

 

Leading Partner

UK Health Security Agency

 

Other Partners Involved

University of Oxford, Barcelona Institute for Global Health

Publications
Publications
Relevant Publications
  • Pollard, J., Graves, N., Whitby, M., & Barnett, A. G. (2024). Umbrella review of economic evaluations of interventions for the prevention and management of healthcare-associated infections in adult hospital patients. Journal of Hospital Infection, 158, 47–60.

    Publication date: 19 March 2025

    Authors: J. Pollard, E. Agnew, N. Pearce-Smith, K.B. Pouwels, N. Salant, J.V. Robotham, and the REVERSE Consortium

    Journal: The Journal of Hospital Infection

    Title: Umbrella review of economic evaluations of interventions for the prevention and management of healthcare-associated infections in adult hospital patients

    Abstract:

    Link(s): https://www.journalofhospitalinfection.com/article/S0195-6701(25)00009-X/fullte…

    File(s): Umbrella Review

background

SUBSCRIBE TO REVERSE NEWS

By filling this form you consent to receiving the REVERSE Newsletter. For more information read our privacy & cookies policy.

CONNECT WITH US